Adult Dosing
Acute musculoskeletal pain
Pediatric Dosing
- Safety and effectiveness in pediatric patients have not been established
See Supplemental Patient Information
- Transient episodes of light-headedness, dizziness or syncope have been reported
- Confusion, anxiety and tremors have been reported with co-administration of propoxyphene with orphenadrine. Consider reduction of dosage and/or discontinuation of one or both of these agents
- Safety of continuous prolonged therapy have not been established; if prescribed for prolonged use, consider periodic monitoring of blood, urine and liver function values
Caution: Use cautiously in
Supplemental Patient Information
- Caution ambulatory patients against engaging in activities requiring mental alertness such as operating machinery or driving a motor vehicle
Pregnancy Category:C
Breastfeeding: Safety unknown.
